Cell Impact AB (CI) — Capital Reinvestment Ratio

Latest as of September 2024: 2.36x

Cell Impact AB (CI) has a Capital Reinvestment Ratio of 2.36x as of September 2024, meaning it reinvests 2% of its operating cash flow (Skr847.00K) in capital expenditures (Skr2.00 Million). See how leveraged is Cell Impact AB's balance sheet to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

2.36x

Capex / Operating Cash Flow

Operating Cash Flow

Skr847.00K

SEK

Capital Expenditures

Skr2.00 Million

SEK

Data as of

Sep 2024

Most recent filing

Annual Capital Reinvestment Ratio for Cell Impact AB (None–None)

Year-by-year Capital Reinvestment Ratio for Cell Impact AB from None to None. For live market cap and broader valuation context, see CI market cap.

Year	Reinvestment Ratio	Operating CF (SEK)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow